Gilead Highlights Collaborative Efforts to Advance Lenacapavir HIV Prevention Launch in South Africa
Gilead Highlights Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa Gilead Sciences has commended the leadership of the Government of South Africa and the Global Fund for…
Azafaros Reports Phase 2 RAINBOW Study Results for Nizubaglustat in Molecular Genetics and Metabolism Journal
Azafaros Announces Publication of Phase 2 RAINBOW Study Results for Nizubaglustat in Molecular Genetics and Metabolism Journal Azafaros, a privately held biotechnology company focused on developing therapies for lysosomal storage…
OliX Pharmaceuticals Secures KRW 110 Billion Investment from BOLD, L’Oréal CVC, and Weiss Asset Management
OliX Pharmaceuticals Raises KRW 110 Billion in Strategic Investment from L’Oréal’s BOLD and Weiss Asset Management OliX Pharmaceuticals, Inc., a leading biotechnology company specializing in RNA interference (RNAi) therapeutics, has…
Taiho Oncology Publishes NEJM Data on First All-Oral Regimen in Newly Diagnosed AML
NEJM Publishes ASCERTAIN-V Trial Results of First All-Oral Decitabine-Cedazuridine Plus Venetoclax Regimen in AML Taiho Oncology, Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies for hematologic malignancies…
Verastem Oncology Receives FDA Fast Track for VS-7375 in Non-Small Cell Lung Cancer
Verastem Oncology’s VS-7375 Receives FDA Fast Track Designation for KRAS G12D-Mutated Non-Small Cell Lung Cancer Verastem Oncology, a biopharmaceutical company focused on developing targeted therapies for cancers driven by the…
VB Spine Funds Research to Develop First Predictive Blood Test for Adolescent Scoliosis
VB Spine Partners to Fund Breakthrough Pediatric Scoliosis Genetics Research Led by Dr. Alain Moreau VB Spine LLC, a global, family-owned spine-focused medical company, has announced a strategic partnership to…
Rezon Bio Appoints Dr. Ralf Otto as Chief Operating Officer to Drive Growth and Expansion
Rezon Bio Appoints Dr. Ralf Otto as Chief Operating Officer to Strengthen Global CDMO Expansion Strategy Rezon Bio, a science-driven European biologics contract development and manufacturing organization (CDMO), has announced…
HSS Sports Medicine Chief Riley J. Williams III Named FIFA Venue Medical Officer for 2026 World Cup
HSS Surgeon Riley J. Williams III Appointed Venue Medical Officer for FIFA World Cup 26™ in New York–New Jersey Region FIFA World Cup 26™ has announced the appointment of Hospital…
Cellares and TScan Therapeutics Partner to Evaluate Automated Manufacturing of TSC-101 for Hematologic Malignancies
Cellares and TScan Therapeutics Collaborate to Evaluate Automated Manufacturing for TSC-101 TCR-T Therapy in AML and MDS Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and TScan Therapeutics, Inc.…
Mission Bio’s Tapestri Identifies AML Patients Likely to Benefit from Motixafortide in BLAST Trial
Mission Bio and German Research Consortium Identify Single-Cell Biomarker Signal That May Predict Motixafortide Benefit in AML Mission Bio, a leader in single-cell multiomics, has jointly announced new findings with…
Fujifilm Announces Leadership Changes to Strengthen Life Sciences Business
Fujifilm Strengthens Life Sciences Leadership Across Biomanufacturing and iPSC Businesses FUJIFILM Holdings America Corporation has announced expanded leadership responsibilities for three senior executives across its Life Sciences Group, reinforcing the…
QT Imaging Secures Saudi FDA Regulatory Clearance
QT Imaging Secures Saudi FDA Approval for Breast Acoustic CT Scanner, Advancing Expansion Across Gulf Healthcare Market QT Imaging Holdings, Inc., a medical device company focused on transforming breast health…